Authorised prescriber applications

Quicklinks


TGA Update on Authorised Prescribers

The Government accepted the Expert Review of Medicines and Medical Devices Regulation recommendation to make changes to the Authorised Prescriber Scheme that will streamline the application process and improve access to required unapproved therapeutic goods.

From 3 July 2017, medical practitioners will not be  required to submit their clinical justification to the TGA for evaluation as this will have already been approved by a Human Research Ethics Committee (HREC) or endorsed by a relevant college.

Applications to become an Authorised Prescriber of therapeutic goods which are deemed to have an established history of use will be eligible for a longer duration of authorisation, at the discretion of the Delegate. The maximum duration of approval will increase from one year to two years for medical devices and from two years to five years for medicines and biologicals.


There are circumstances where patients may require access to medicines or medical devices that have not been approved for supply by the TGA.

In these circumstances a medical practitioner may be granted authority to become an authorised prescriber of a specified unapproved therapeutic good (or class of unapproved therapeutic goods) to specific patients (or classes of recipients) with a particular medical condition.

The medical practitioner becomes an 'Authorised Prescriber' and can prescribe that product for that condition (also known as the 'indication') to individual patients in their immediate care without further TGA approval.

To be an Authorised Prescriber the medical practitioner must have:

  • The training and expertise appropriate for the condition being treated and the proposed use of the product
  • The Authorised Prescriber must be able to best determine the needs of the patient
  • To monitor the outcome of therapy.

The following key points should be noted by the applicant:

  • The applicant must be a fully registered medical practitioner, and must have the training and expertise appropriate for the condition being treated and the proposed use of the product
  • The applicant must be an employee of, and practicing at, Barwon Health, and should not use the product in a private setting
  • The applicant must be able to best determine the needs of the patient and must be able to monitor the outcome of the therapy
  • The intended unapproved product should not be intended for use in a clinical trial
  • There should be no conflicts of interest.

An Authorised Prescriber is allowed to supply the product directly to specified patients under their immediate care and not to other practitioners who prescribe/administer the product. Use of the product under an authorisation must be at all times in line with the conditions specified in the authorisation.

Once a medical practitioner becomes an 'Authorised Prescriber' they do not need to notify the TGA when they are prescribing the unapproved product, however they must report to the TGA the number of patients treated on a six monthly basis.

 

Please refer to the Authorised Prescriber Application Guide at the top of this page for new applications to become an Authorised Prescriber.

As per Authorised Prescriber conditions, approval is granted for specific durations which may vary between one year and two years depending on the product - please refer to the Renewal of Authorised Prescriber Application Guide at the top of this page for Authorised Prescriber applications which require renewing.

Below are a list of supporting documents which may be required to be submitted as part of your application.

 

Supporting documents:

Traditional Owners

We, Barwon Health, acknowledge the Traditional Owners of the land, the Wadawurrung people of the Kulin Nation. We pay our respects to the Elders both past and present.